GlassScriptPhysician profile
Sarah Rose Rocks
NPI 1033625397
$2,168.21
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,427 · 2022: $742.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $727.35 | 2021-2022 | |
| Bioventus LLC | $320.85 | 2021-2022 | |
| Radius Health, INC. | $271.16 | 2021-2022 | |
| Stryker Corporation | $205.55 | 2021-2022 | |
| Dynasplint Systems INC. | $201.19 | 2021 | |
| Amgen INC. | $156.94 | 2021-2022 | |
| Pacira Therapeutics, INC. | $155.78 | 2021 | |
| Si-Bone, INC. | $26.48 | 2021 | |
| Zimmer Biomet Holdings, INC. | $19.97 | 2021 | |
| Fidia Pharma USA INC. | $19.67 | 2022 | |
| Heron Therapeutics, INC. | $18.63 | 2021 | |
| Abbvie INC. | $16.81 | 2021 | |
| Alvogen INC | $16.10 | 2022 | |
| Horizon Therapeutics Plc | $11.73 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Rocks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.